INS and metabolic dysfunction-associated steatotic liver disease: The pancreatic β cells compensatively increase insulin synthesis and secretion, resulting in hyperinsulinemia and increased synthesis of new fatty acids in the liver, leading to a nonalcoholic fatty liver disease (NAFLD).